Deep learning pose estimation for phenotyping of co‐occurring hyperkinetic movement disorders

Type
01A - Journal article
Editors
Editor (Corporation)
Supervisor
Parent work
Annals of Clinical and Translational Neurology
Special issue
DOI of the original publication
Link
Related research data
Series
Series number
Volume
Issue / Number
Pages / Duration
Patent number
Publisher / Publishing institution
Wiley
Place of publication / Event location
Edition
Version
Programming language
Assignee
Practice partner / Client
Abstract
OBJECTIVE: To explore whether routine outpatient video combined with deep learning-based pose estimation and clinically interpretable kinematic features can support multi-label phenotyping of co-occurring hyperkinetic movement disorders (HMDs). METHODS: In this exploratory single-centre proof-of-concept study, videos from 21 patients with HMDs and 4 healthy controls were processed with markerless pose estimation (YOLOv8) and 2-dimensional keypoint trajectories transformed into kinematic descriptors spanning statistical, temporal, spectral, and complexity domains. Ten-second windows were aligned to expert annotations for eight hyperkinetic phenomenologies. Conventional supervised classifiers were trained on these tabular descriptors. Window-level predictions were aggregated to the patient level, and label-specific thresholds were tuned on training participants only. RESULTS: In patient-level multi-label performance reporting, (i) the best single pipeline selected by discrimination (StandardScaler + MLP) achieved a macro-AUPRC of 0.821 ± 0.019 and a macro-receiver operating characteristic area under the curve of 0.830 ± 0.029. (ii) The best single pipeline selected by Hamming accuracy (MinMaxScaler + SVM) reached 0.764 ± 0.041. (iii) Under prespecified nested cross-validation with per-label model selection within training folds (primary analysis), macro-AUPRC was 0.717 ± 0.030, macro-AUROC was 0.767 ± 0.069, Hamming accuracy was 0.764 ± 0.014 and patient-label agreement was 153/200 (76.5%). (iv) Post hoc per-label selection of the best-performing pipeline defined an exploratory upper bound of 172/200 (86.0%). INTERPRETATION: In this exploratory study, a hybrid pipeline combining deep learning pose estimation with feature-engineered supervised classification produced encouraging patient-level multi-label performance for co-occurring HMDs. These findings are proof-of-concept; external, multicentre, prospective validation is required before clinical or trial use.
Keywords
Project
Event
Exhibition start date
Exhibition end date
Conference start date
Conference end date
Date of the last check
ISBN
ISSN
2328-9503
Language
English
Created during FHNW affiliation
Yes
Strategic action fields FHNW
Publication status
Published
Review
peer-reviewed
Open access category
Gold
License
'https://creativecommons.org/licenses/by/4.0/'
Citation
Cif, L., Demailly, D., Horvàth, G. A., Ortigoza‐Escobar, J. D., Dorison, N., Jimenez, M. C., Hubsch, C. A., Wirth, T., Hariz, G.-M., Huby, S., Dornadic, M., Souei, Z., Rehman, M. M. U., Hemm-Ode, S., Boulaymen, M., Moraud, E. M., Bloch, J., & Vasques, X. (2026). Deep learning pose estimation for phenotyping of co‐occurring hyperkinetic movement disorders. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70474